Chamas for Change Validation

June 13, 2017 updated by: Astrid Christoffersen-Deb, Moi University

Chamas for Change: Validating an Integrated Community-based Strategy of Peer Support in Pregnancy and Infancy in Kenya

This team has shown that chamas can be tailored to increase the uptake of health services in pregnancy and infancy, sustain themselves beyond the period of funding and become integrated within a county's health strategy. However, further investment is warranted to validate this intervention in a new region to ensure the positive effects on MNCH are a result of chamas and can be replicated. The purpose of this study is to demonstrate that chamas are an effective service-delivery platform for improving women's and children's health and well-being in western Kenya.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

The objectives are:

To test the effectiveness of chamas as an intervention on improving:

  • Health services uptake (Facility delivery, attendance of 4 or more ANC visits, Visit by a CHV within 48 hours of birth, immunization uptake at 6 months-of-age, long-term FP uptake)
  • Health behaviors and care practices (exclusive breastfeeding to 6 months)
  • Women's Empowerment, peer support, parental stress, and harsh punishmennt within the home
  • Maternal and infant morbidity (low birth weight, diarrhea in the last month, preterm deliveries)
  • Maternal, perinatal, neonatal and infant mortality

To perform a qualitative evaluation to better understand women's and CHV's experience with chamas and understand how chamas affect peer support

To perform a process evaluation

To perform a cost effectiveness analysis on chamas.

The investigators plan to use a cluster randomized controlled design because the intervention is delivered in groups that are based within Community Units (CUs). We know that some of the positive effects of chamas expand to the community surrounding the chama. By randomizing clusters, we will hope to isolate these communities in order to understand the individual effects of chamas. The unit of randomization and implementation will be Community Units (CU). Because there are only 77 of the 163 CUs with active Community Health Workers trained by AMPATH, we will draw our intervention and control groups from these active units. By doing this, the control group is receiving the standard of care per the MOH and AMPATH community strategy. We will randomly assign each of the 77 active CUs in the four sub-counties to the chama intervention (arm 1) or to act as a control region (arm 2). We will evaluate individual outcomes on women enrolled in the study. The CUs that do not participate in the study will serve as buffer areas.

Study Type

Interventional

Enrollment (Anticipated)

3040

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Trans-Nzoia
      • Kitale, Trans-Nzoia, Kenya
        • Recruiting
        • Trans-Nzoia MOH Health Centers
        • Contact:
        • Principal Investigator:
          • Julia Songok, MBCHb
        • Sub-Investigator:
          • Astrid Christoffersen-Deb, MDCM
        • Sub-Investigator:
          • Laura Ruhl, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 50 years (Child, Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Pregnant women < 28 weeks, and their newborn infants following birth

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Chama cha MamaToto
Women attending chamas will meet twice per month, receive social and health education from CHVs and participate in a savings/loans program.
Chamas are a community-led model of peer support for women in pregnancy and infancy. Chamas are highly gendered institutions that women have relied on for survival to pool resources. Using this existing cultural script, chamas have been tailored to the needs of pregnant women. Central to the approach is the integration of health, social and financial literacy education with a savings/loans program. Chamas are designed to improve MNCH by generating positive peer support for women to advocate for themselves and account for the care they receive.
No Intervention: Control
The CHVs in the control group will be given refresher training on health roles they are supposed to play according to the standard MOH activities

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Skilled Delivery
Time Frame: 1 year
Proportion of women delivering in a health facility based on questionnaire
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Antenatal Care
Time Frame: 1 year
Proportion of women attending 4 or more ANC visits based on questionnaire
1 year
Exclusive Breastfeeding
Time Frame: 17 months
Proportion of women introducing solid foods after 6 months of age based on questionnaire
17 months
Contraception
Time Frame: 17 months
Proportion of women initiating Long-Acting Reversible Contraception based on questionnaire
17 months
Health Insurance
Time Frame: 1 year
Proportion of women with Health Insurance based on questionnaire
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Astrid Christoffersen-Deb, MDCM, Moi University
  • Principal Investigator: Julia Songok, MBChB, MMed, Moi University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2017

Primary Completion (Anticipated)

July 1, 2018

Study Completion (Anticipated)

December 1, 2018

Study Registration Dates

First Submitted

May 31, 2017

First Submitted That Met QC Criteria

June 13, 2017

First Posted (Actual)

June 15, 2017

Study Record Updates

Last Update Posted (Actual)

June 15, 2017

Last Update Submitted That Met QC Criteria

June 13, 2017

Last Verified

June 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • MoiU1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy Related

Clinical Trials on Chama cha MamaToto

3
Subscribe